J

Jafron Biomedical Co Ltd
SZSE:300529

Watchlist Manager
Jafron Biomedical Co Ltd
SZSE:300529
Watchlist
Price: 30.07 CNY 1.9% Market Closed
Market Cap: 24B CNY
Have any thoughts about
Jafron Biomedical Co Ltd?
Write Note

Wall Street
Price Targets

Price Targets Summary
Jafron Biomedical Co Ltd

Wall Street analysts forecast Jafron Biomedical Co Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Jafron Biomedical Co Ltd is 43.26 CNY with a low forecast of 42.83 CNY and a high forecast of 44.53 CNY.

Lowest
Price Target
42.83 CNY
42% Upside
Average
Price Target
43.26 CNY
44% Upside
Highest
Price Target
44.53 CNY
48% Upside
Jafron Biomedical Co Ltd Competitors:
Price Targets
DEMANT
Demant A/S
17% Upside
FPH
Fisher & Paykel Healthcare Corporation Ltd
5% Downside
MEDI
Medistim ASA
17% Upside
ELN
El En SpA
19% Upside
BSX
Boston Scientific Corp
13% Upside
SRDX
Surmodics Inc
11% Upside
300298
Sinocare Inc
34% Upside
VREX
Varex Imaging Corp
59% Upside

Revenue
Forecast

Revenue Estimate
Jafron Biomedical Co Ltd

For the last 8 years the compound annual growth rate for Jafron Biomedical Co Ltd's revenue is 18%. The projected CAGR for the next 3 years is 38%.

18%
Past Growth
38%
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Jafron Biomedical Co Ltd

For the last 8 years the compound annual growth rate for Jafron Biomedical Co Ltd's operating income is 11%. The projected CAGR for the next 3 years is 58%.

11%
Past Growth
58%
Estimated Growth
Estimates Accuracy
1%
Average Beat

Net Income
Forecast

Net Income Estimate
Jafron Biomedical Co Ltd

For the last 8 years the compound annual growth rate for Jafron Biomedical Co Ltd's net income is 10%. The projected CAGR for the next 3 years is 58%.

10%
Past Growth
58%
Estimated Growth
Estimates Accuracy
0%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Jafron Biomedical Co Ltd's stock price target?
Price Target
43.26 CNY

According to Wall Street analysts, the average 1-year price target for Jafron Biomedical Co Ltd is 43.26 CNY with a low forecast of 42.83 CNY and a high forecast of 44.53 CNY.

What is Jafron Biomedical Co Ltd's Revenue forecast?
Projected CAGR
38%

For the last 8 years the compound annual growth rate for Jafron Biomedical Co Ltd's revenue is 18%. The projected CAGR for the next 3 years is 38%.

What is Jafron Biomedical Co Ltd's Operating Income forecast?
Projected CAGR
58%

For the last 8 years the compound annual growth rate for Jafron Biomedical Co Ltd's operating income is 11%. The projected CAGR for the next 3 years is 58%.

What is Jafron Biomedical Co Ltd's Net Income forecast?
Projected CAGR
58%

For the last 8 years the compound annual growth rate for Jafron Biomedical Co Ltd's net income is 10%. The projected CAGR for the next 3 years is 58%.

Back to Top